Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis

被引：0
|
作者：
Yin, Cong [1 ]
Li, Juan [1 ,3 ]
Yuan, Lin [2 ]
机构：
[1] Hubei Univ Chinese Med, Hubei Prov Key Lab Tradit Chinese Med Resource & C, Wuhan, Hubei, Peoples R China
[2] Hubei Minzu Univ, Hubei Prov Key Lab Occurrence & Intervent Rheumat, Enshi, Hubei, Peoples R China
[3] Hubei Univ Chinese Med, Coll Pharm, Hubei Prov Key Lab Tradit Chinese Med Resource & C, Huang Jia Hu West Rd 16, Wuhan 430065, Hubei, Peoples R China
来源：
CLINICAL CARDIOLOGY | 2023年 / 46卷 / 05期
关键词：
D O I：
10.1002/clc.23994
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [21] The Effect of Tolvaptan on Metabolism and Electrolyte Homeostasis in Patients with Heart Failure: A Systematic Review and Meta-Analysis
    Xiao, Yao
    Chen, Yue
    Zuo, Xianghao
    Mutalifu, Kadireya
    Chen, Xiaoping
    Liu, Kai
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (09)
  • [22] Effects of Tolvaptan on Volume Overload in Patients with Heart Failure Meta-Analysis of Randomized Controlled Trials
    Kinugawa, Koichiro
    Sato, Naoki
    Inomata, Takayuki
    INTERNATIONAL HEART JOURNAL, 2018, 59 (06) : 1368 - 1377
  • [23] The Impact of Early Tolvaptan Administration in the Patients Admitted by Acute Decompensated Heart Failure
    Tsukamoto, Kei
    Oyabu, Kenjiro
    Hamada, Kazuyuki
    Hasegawa, Syun
    Watanabe, Masahiro
    Saitou, Takashi
    Mizobuchi, Keiko
    Ajiro, Youichi
    Mori, Fumiaki
    Iwade, Kazunori
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S187 - S187
  • [24] Potential benefits of yoga in patients with heart failure: A meta-analysis of controlled trials
    Moeckel, Luis
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2019, 31
  • [25] The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta-analysis
    Long, Yu-Xiang
    Hu, Yue
    Cui, Di-Yu
    Hu, Shuang
    Liu, Zeng-Zhang
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (02): : 225 - 234
  • [26] Evaluating the safety and effectiveness of tolvaptan in patients with heart failure and renal impairment: a systematic review and meta-analysis
    Aashish Kumar
    Umer Iqbal
    Shafin Bin Amin
    Syed Ali Arsal
    Syed Muhammad Sinaan Ali
    Muhammad Ashir Shafique
    Muhammad Saad Shahid
    Aimen Naz
    Emediong Santhus Asuka
    European Journal of Clinical Pharmacology, 2025, 81 (2) : 203 - 216
  • [27] Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
    Wu, Mei-Yi
    Chen, Tzu-Ting
    Chen, Ying-Chun
    Tarng, Der-Cherng
    Wu, Yun-Chun
    Lin, Hsien-Ho
    Tu, Yu-Kang
    PLOS ONE, 2017, 12 (09):
  • [28] Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis
    Zhao, Xuecheng
    Zhang, Da-Qi
    Song, Rongjing
    Zhang, Guoqiang
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [29] Effect of levosimendan in patients with acute decompensated heart failure A meta-analysis
    Zhou, S.
    Zhang, L.
    Li, J.
    HERZ, 2019, 44 (07) : 630 - 636
  • [30] Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis
    Teerlink, John R.
    Davison, Beth A.
    Cotter, Gad
    Maggioni, Aldo P.
    Sato, Naoki
    Chioncel, Ovidiu
    Ertl, Georg
    Felker, G. Michael
    Filippatos, Gerasimos
    Greenberg, Barry H.
    Pang, Peter S.
    Ponikowski, Piotr
    Edwards, Christopher
    Senger, Stefanie
    Teichman, Sam L.
    Nielsen, Olav Wendelboe
    Voors, Adriaan A.
    Metra, Marco
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (02) : 315 - 329
12345